LMNB1

lamin B1, the group of Lamins

Basic information

Region (hg38): 5:126776622-126837020

Links

ENSG00000113368NCBI:4001OMIM:150340HGNC:6637Uniprot:P20700AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • microcephaly (Strong), mode of inheritance: AD
  • adult-onset autosomal dominant demyelinating leukodystrophy (Limited), mode of inheritance: AD
  • autosomal dominant primary microcephaly (Supportive), mode of inheritance: AD
  • adult-onset autosomal dominant demyelinating leukodystrophy (Supportive), mode of inheritance: AD
  • adult-onset autosomal dominant demyelinating leukodystrophy (Strong), mode of inheritance: AD
  • microcephaly 26, primary, autosomal dominant (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Leukodystrophy, demyelinating, adult-onset, autosomal dominant; Microcephaly 26, primary, autosomal dominantADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Neurologic16951681; 19151023; 21225301; 21909802; 23243074; 23649844; 32910914; 33033404

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LMNB1 gene.

  • Microcephaly 26, primary, autosomal dominant (3 variants)
  • Syndrome with microcephaly as major feature (3 variants)
  • Inborn genetic diseases (2 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMNB1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
23
clinvar
13
clinvar
38
missense
2
clinvar
88
clinvar
8
clinvar
4
clinvar
102
nonsense
2
clinvar
2
start loss
1
clinvar
1
frameshift
3
clinvar
3
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
4
8
1
13
non coding
19
clinvar
14
clinvar
22
clinvar
55
Total 3 1 118 45 39

Variants in LMNB1

This is a list of pathogenic ClinVar variants found in the LMNB1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-126776801-G-C Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350594
5-126776804-G-T Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350595
5-126776808-C-T Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350596
5-126776821-G-A Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350597
5-126776874-T-C Leukodystrophy, Adult-Onset Likely benign (Jun 14, 2016)350598
5-126776888-T-C Leukodystrophy, Adult-Onset Benign (Jun 14, 2016)350599
5-126776914-G-A Leukodystrophy, Adult-Onset Likely benign (Jun 14, 2016)350600
5-126776926-G-C Leukodystrophy, Adult-Onset Conflicting classifications of pathogenicity (Oct 01, 2022)350601
5-126776932-C-T Leukodystrophy, Adult-Onset Likely benign (Jun 14, 2016)350602
5-126776957-G-A Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350603
5-126776969-G-A Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350604
5-126777018-T-C Leukodystrophy, Adult-Onset Likely benign (Jun 14, 2016)350605
5-126777072-C-G Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350606
5-126777127-C-G Leukodystrophy, Adult-Onset Uncertain significance (Jun 14, 2016)350607
5-126777195-C-T Adult-onset autosomal dominant demyelinating leukodystrophy Benign (Jan 13, 2018)350608
5-126777211-G-T Adult-onset autosomal dominant demyelinating leukodystrophy Benign (Jan 12, 2018)350609
5-126777350-C-G Adult-onset autosomal dominant demyelinating leukodystrophy Uncertain significance (Jan 13, 2018)350610
5-126777433-G-T Adult-onset autosomal dominant demyelinating leukodystrophy Uncertain significance (Jan 13, 2018)906293
5-126777509-A-G Uncertain significance (Jan 18, 2022)1697142
5-126777521-A-G Uncertain significance (May 21, 2021)1188065
5-126777523-C-T Likely benign (Oct 07, 2022)1976718
5-126777524-C-T Inborn genetic diseases Conflicting classifications of pathogenicity (Jan 13, 2023)2234603
5-126777526-C-T Likely benign (Jan 13, 2023)2960650
5-126777531-C-A Inborn genetic diseases Uncertain significance (Jan 23, 2024)3119312
5-126777537-G-T LMNB1-related disorder Benign/Likely benign (Nov 22, 2023)1563912

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LMNB1protein_codingprotein_codingENST00000261366 1160398
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5550.4451257350101257450.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.632293100.7400.00001663811
Missense in Polyphen4072.9570.548261019
Synonymous0.4141081140.9510.000005951114
Loss of Function3.92628.60.2100.00000136371

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005790.0000579
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00006190.0000615
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin.;
Disease
DISEASE: Leukodystrophy, demyelinating, autosomal dominant, adult- onset (ADLD) [MIM:169500]: A slowly progressive and fatal demyelinating leukodystrophy, presenting in the fourth or fifth decade of life. Clinically characterized by early autonomic abnormalities, pyramidal and cerebellar dysfunction, and symmetric demyelination of the CNS. It differs from multiple sclerosis and other demyelinating disorders in that neuropathology shows preservation of oligodendroglia in the presence of subtotal demyelination and lack of astrogliosis. {ECO:0000269|PubMed:16951681}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Apoptosis - Homo sapiens (human);Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer,s disease models;Neurodegenerative Diseases;Disease;tnfr1 signaling pathway;caspase cascade in apoptosis;hiv-1 nef: negative effector of fas and tnf;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular Senescence;Cellular responses to stress;Breakdown of the nuclear lamina;Apoptotic cleavage of cellular proteins;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Cellular responses to external stimuli;Depolymerisation of the Nuclear Lamina;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Caspase Cascade in Apoptosis (Consensus)

Recessive Scores

pRec
0.521

Intolerance Scores

loftool
0.181
rvis_EVS
-0.4
rvis_percentile_EVS
26.53

Haploinsufficiency Scores

pHI
0.932
hipred
Y
hipred_score
0.739
ghis
0.611

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.889

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lmnb1
Phenotype
skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; respiratory system phenotype; embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
interleukin-12-mediated signaling pathway
Cellular component
nucleus;nuclear envelope;nuclear inner membrane;lamin filament;nucleoplasm;membrane;nuclear matrix;nuclear membrane
Molecular function
structural molecule activity;protein binding;phospholipase binding;sequence-specific double-stranded DNA binding